I-Mab's 15min chart triggers RSI oversold, KDJ golden cross formation.

The 15-minute chart for I-Mab has triggered a reading of RSI Oversold, accompanied by a KDJ Golden Cross at 08/29/2025 10:00. This indicates that the stock price has declined rapidly and is currently trading below its fundamental support level. Furthermore, the momentum of the stock price is shifting towards an upward trajectory, suggesting that it has the potential to continue increasing in value.

On July 02, 2025, I-Mab experienced a significant price decline, with its 15-minute chart triggering an RSI Oversold reading and a KDJ Golden Cross at 08:00 AM. These technical indicators suggest that the stock price has rapidly fallen below its fundamental support level and is poised for an upward momentum shift.

The RSI (Relative Strength Index) Oversold reading indicates that the stock has been oversold, meaning it has declined to a level where it is considered undervalued. The KDJ Golden Cross, a bullish signal, occurs when the K line crosses above the D line, signaling a potential reversal in the stock's downward trend. This combination of technical signals suggests that I-Mab may be due for a price rebound.

The stock's price decline may be attributed to short-term liquidity shifts or institutional pressure, as seen in the case of Tharimmune (THAR.O) [1]. Despite no major news, Tharimmune experienced a sharp drop of 13.75% intraday, driven by liquidity crunches or algorithmic sell-offs. Similarly, I-Mab's price movement could be influenced by short-term sentiment shifts or algorithmic trading activities.

The divergence in performance from peer stocks in the biotech sector also supports the hypothesis of stock-specific factors driving I-Mab's decline. While some biotech stocks showed positive gains, others like I-Mab experienced significant losses, indicating that the move is likely due to short-term events rather than broader sector trends.

Given the technical signals and peer stock performance, investors should closely monitor I-Mab's price movements. The potential for an upward momentum shift suggests that the stock may be undervalued and could experience a price rebound. However, investors should remain cautious and consider conducting further analysis before making investment decisions.

References:
[1] https://www.ainvest.com/news/caused-tharimmune-thar-plunge-13-75-intraday-technical-order-flow-deep-dive-2508/